deferoxamine has been researched along with lead in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Granick, S; Sinclair, PR | 1 |
| García, R; Granadillo, VA; Rodríguez-Iturbe, B; Romero, RA; Salgado, O | 1 |
| Bannon, D; Bressler, J; Cheong, JH; Kim, Y; Olivi, L | 1 |
| Crawford, RL; Paszczynski, AJ; Zawadzka, AM | 1 |
| Gu, J; Lewis, RS | 1 |
| Bátka, D; Farkas, E; Kremper, G; Pócsi, I | 1 |
| Bunker, BA; Haack, EA; Maurice, PA; Mishra, B | 1 |
| Barton, LE; Grant, KE; Kosel, T; Maurice, PA; Quicksall, AN | 1 |
| Cahill, CM; Jiang, H; Liu, Y; Rogers, JT; Smith, A; Tummala, V; Venkataramani, V; Washburn, C | 1 |
| Aminzadeh, A; Gazeri, A | 1 |
10 other study(ies) available for deferoxamine and lead
| Article | Year |
|---|---|
Heme control on the synthesis of delta-aminolevulinic acid synthetase in cultured chick embryo liver cells.
Topics: 5-Aminolevulinate Synthetase; Allylisopropylacetamide; Animals; Cells, Cultured; Chick Embryo; Deferoxamine; Enzyme Induction; Heme; Hemin; Kinetics; Lead; Levulinic Acids; Liver; Phenobarbital; Protein Biosynthesis; Transcription, Genetic | 1975 |
Desferrioxamine B increases urinary lead excretion.
Topics: Deferoxamine; Humans; Lead; Lead Poisoning; Male; Middle Aged | 1993 |
Different mechanisms mediate uptake of lead in a rat astroglial cell line.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Anion Transport Proteins; Astrocytes; Cation Transport Proteins; Cell Line; Deferoxamine; Hydrogen-Ion Concentration; Iron; Iron Chelating Agents; Iron-Binding Proteins; Kinetics; Lead; Rats | 2004 |
Pyridine-2,6-bis(thiocarboxylic acid) produced by Pseudomonas stutzeri KC reduces chromium(VI) and precipitates mercury, cadmium, lead and arsenic.
Topics: Arsenic; Cadmium; Carcinogens, Environmental; Chemical Precipitation; Chromium; Deferoxamine; Hydrogen-Ion Concentration; Lead; Mercury; Molecular Structure; Oxidation-Reduction; Pseudomonas stutzeri; Pyridines; Siderophores; Spectrometry, Mass, Electrospray Ionization; Sulfides | 2007 |
Effect of pH and metal ions on the decomposition rate of S-nitrosocysteine.
Topics: Buffers; Cadmium; Chelating Agents; Copper; Cysteine; Deferoxamine; Drug Stability; Hydrogen-Ion Concentration; Ions; Iron; Kinetics; Lead; Mercury; Metals, Heavy; S-Nitrosothiols; Spectrophotometry, Ultraviolet | 2007 |
Structure-based differences between the metal ion selectivity of two siderophores desferrioxamine B (DFB) and desferricoprogen (DFC): why DFC is much better Pb(II) sequestering agent than DFB?
Topics: Calcium; Cations, Divalent; Chromium; Deferoxamine; Diketopiperazines; Hydroxamic Acids; Lead; Ligands; Magnesium; Metals; Siderophores; Structure-Activity Relationship | 2008 |
Effects of the microbial siderophore DFO-B on Pb and Cd speciation in aqueous solution.
Topics: Bacteria; Biodegradation, Environmental; Cadmium; Deferoxamine; Hydrogen-Ion Concentration; Lead; Siderophores; Solutions; Water | 2009 |
Size-dependent Pb sorption to nanohematite in the presence and absence of a microbial siderophore.
Topics: Adsorption; Deferoxamine; Ferric Compounds; Lead; Nanoparticles; Particle Size | 2011 |
A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Deferoxamine; Gene Expression Regulation; Homeostasis; Humans; Iron; Iron Chelating Agents; Lead; Neuroblastoma; Neurons; Neurotoxicity Syndromes; Protein Biosynthesis | 2016 |
Protective effects of deferoxamine on lead-induced cardiotoxicity in rats.
Topics: Adult; Animals; Cardiotoxicity; Deferoxamine; Dose-Response Relationship, Drug; Female; Humans; Iron Chelating Agents; Lead; Male; Middle Aged; Models, Animal; Occupational Diseases; Occupational Exposure; Oxidative Stress; Rats; Rats, Wistar | 2020 |